Lilly/Icos Cialis Marketing Plan Will Target Four Million Former Viagra Users

Marketing efforts for Lilly/Icos' pending erectile dysfunction treatment Cialis will target the approximately four million patients who have discontinued Pfizer's Viagra (sildenafil).